Maanasa Indaram, MD

People with trisomy 21, or Down syndrome, have a significantly elevated risk for keratoconus, with many reports citing a 30% prevalence of keratoconus in this population.

There has been a sea change in the care of patients with keratoconus in the U.S. since the FDA approval of iLink corneal collagen cross-linking in 2016.

When children and teens present with early onset of keratoconus, we often see severe disease and rapid progression.